NL7213959A - - Google Patents

Info

Publication number
NL7213959A
NL7213959A NL7213959A NL7213959A NL7213959A NL 7213959 A NL7213959 A NL 7213959A NL 7213959 A NL7213959 A NL 7213959A NL 7213959 A NL7213959 A NL 7213959A NL 7213959 A NL7213959 A NL 7213959A
Authority
NL
Netherlands
Application number
NL7213959A
Other versions
NL166470C (en
NL166470B (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7213959A publication Critical patent/NL7213959A/xx
Priority to NLAANVRAGE8100488,A priority Critical patent/NL172654C/en
Publication of NL166470B publication Critical patent/NL166470B/en
Application granted granted Critical
Publication of NL166470C publication Critical patent/NL166470C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL7213959.A 1971-10-29 1972-10-16 METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVERING AND THE DISSOLUTION OF STOMINIC ACID AGAINST ACTION, AND METHOD FOR PREPARING PYRIMIDIN COMPOUNDS USED THEREIN NL166470C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE8100488,A NL172654C (en) 1971-10-29 1981-02-02 METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVING ACTION, METHOD FOR PREPARING PYRIMIDINE COMPOUNDS USED THEREIN, AND FORMED MEDICINAL PRODUCT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (3)

Publication Number Publication Date
NL7213959A true NL7213959A (en) 1973-05-02
NL166470B NL166470B (en) 1981-03-16
NL166470C NL166470C (en) 1981-08-17

Family

ID=22715935

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7213959.A NL166470C (en) 1971-10-29 1972-10-16 METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVERING AND THE DISSOLUTION OF STOMINIC ACID AGAINST ACTION, AND METHOD FOR PREPARING PYRIMIDIN COMPOUNDS USED THEREIN

Country Status (25)

Country Link
JP (2) JPS5337870B2 (en)
AR (2) AR198798A1 (en)
AT (2) AT320656B (en)
AU (1) AU467600B2 (en)
BE (1) BE790125A (en)
CA (1) CA980778A (en)
CH (2) CH555832A (en)
DE (3) DE2264657C2 (en)
DK (1) DK131465B (en)
EG (1) EG11013A (en)
ES (2) ES407730A1 (en)
FI (1) FI55503C (en)
FR (1) FR2157865B1 (en)
GB (2) GB1377308A (en)
IE (1) IE37043B1 (en)
IL (2) IL40458A (en)
LU (1) LU66304A1 (en)
NL (1) NL166470C (en)
NO (1) NO136574C (en)
PH (2) PH10129A (en)
PL (2) PL84634B1 (en)
SE (2) SE393376B (en)
SU (2) SU498908A3 (en)
YU (2) YU35125B (en)
ZA (1) ZA727362B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (en) * 1979-04-17 1980-11-01
JPS5752409Y2 (en) * 1979-11-05 1982-11-15
DE3222914A1 (en) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg SUBSTITUTED 5-PHENYLTHIO-6-AMINO-PYRIMIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE, AND PREPARATIONS CONTAINING THESE COMPOUNDS
JPH0655686B2 (en) * 1988-08-30 1994-07-27 宇部興産株式会社 Process for producing p-bromophenoxyacetaldehyde dialkyl acetals
KR101577554B1 (en) 2005-08-22 2015-12-14 멜리어 파마슈티칼스 아이, 인코포레이티드 Methods and formulations for modulating lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
CA3059432A1 (en) 2017-04-10 2018-10-18 Melior Pharmaceuticals I, Inc. Compositions comprising a lyn kinase activator and a trpms agonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
ES407730A1 (en) 1976-01-16
SE397090B (en) 1977-10-17
ES436624A1 (en) 1977-02-01
DK131465B (en) 1975-07-21
PH11594A (en) 1978-03-31
PH10129A (en) 1976-09-02
DE2264374B2 (en) 1980-08-07
NL166470C (en) 1981-08-17
FI55503C (en) 1979-08-10
SE7505279L (en) 1975-05-06
ZA727362B (en) 1973-11-28
CA980778A (en) 1975-12-30
PL84634B1 (en) 1976-04-30
IL40458A0 (en) 1972-11-28
DK131465C (en) 1975-12-08
GB1377720A (en) 1974-12-18
SU505362A3 (en) 1976-02-28
DE2248741B2 (en) 1974-11-14
YU255172A (en) 1980-03-15
IL48790A (en) 1976-05-31
CH555832A (en) 1974-11-15
PL89852B1 (en) 1976-12-31
DE2264657C2 (en) 1982-09-16
JPS5422995B2 (en) 1979-08-10
IL48790A0 (en) 1976-03-31
DE2248741A1 (en) 1973-05-03
IE37043L (en) 1973-04-29
DE2264374A1 (en) 1973-05-24
CH549579A (en) 1974-05-31
FR2157865B1 (en) 1975-10-31
FI55503B (en) 1979-04-30
AT320656B (en) 1975-02-25
EG11013A (en) 1976-11-30
NO136574B (en) 1977-06-20
YU35125B (en) 1980-09-25
JPS4852780A (en) 1973-07-24
GB1377308A (en) 1974-12-11
SU498908A3 (en) 1976-01-05
IE37043B1 (en) 1977-04-27
AU4722872A (en) 1974-04-04
SE393376B (en) 1977-05-09
DE2264374C3 (en) 1981-07-23
LU66304A1 (en) 1973-05-03
AR196263A1 (en) 1973-12-10
NO136574C (en) 1977-09-28
FR2157865A1 (en) 1973-06-08
IL40458A (en) 1976-05-31
AR198798A1 (en) 1974-07-24
JPS5337870B2 (en) 1978-10-12
DE2248741C3 (en) 1975-06-26
NL166470B (en) 1981-03-16
YU99179A (en) 1981-08-31
AU467600B2 (en) 1975-12-04
DE2264657A1 (en) 1974-06-20
AT321308B (en) 1975-03-25
YU36295B (en) 1982-06-18
BE790125A (en) 1973-04-16
JPS53116386A (en) 1978-10-11

Similar Documents

Publication Publication Date Title
ATA136472A (en)
FR2157865B1 (en)
AR196074A1 (en)
AU2658571A (en)
AU2691671A (en)
AU2742671A (en)
AU2564071A (en)
AU2485671A (en)
AU2894671A (en)
AU2684071A (en)
AU2455871A (en)
AU2726271A (en)
AR202997Q (en)
AU2577671A (en)
AU1109576A (en)
AU2588771A (en)
AU2654071A (en)
AR192311Q (en)
AU2399971A (en)
AU2669471A (en)
AU2885171A (en)
AU3038671A (en)
AU2486471A (en)
AU2684171A (en)
AR199640Q (en)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee